Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- FLRY3.SA
- Price
- 15.08
- Stock movement up
- +0.27 (1.82%)
- Company name
- Fleury S.A.
- Exchange
- (SA ,
- Currency
- BRL )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 8.22B
- Ent value
- 16.31B
- Price/Sales
- 1.02
- Price/Book
- 1.50
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 13.69
- Forward P/E
- 12.16
- PEG
- -
- EPS growth
- 3.81%
- 1 year return
- 13.13%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-12-12
DIVIDENDS
FLRY3.SA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 13.69 |
| Price to OCF | 3.93 |
| Price to FCF | 5.31 |
| Price to EBITDA | 3.59 |
| EV to EBITDA | 7.13 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.02 |
| Price to Book | 1.50 |
| EV to Sales | 2.02 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 545.02M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | 1.24 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 11.69M |
| Net receivables | 1.91B |
| Total current assets | 4.86B |
| Goodwill | 4.41B |
| Intangible assets | 1.55B |
| Property, plant and equipment | 6.02B |
| Total assets | 13.58B |
| Accounts payable | 721.34M |
| Short/Current long term debt | 5.51B |
| Total current liabilities | 2.20B |
| Total liabilities | 8.10B |
| Shareholder's equity | 5.48B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 14.80 |
| Daily high | 15.14 |
| Daily low | 14.80 |
| Daily Volume | 1.54M |
| All-time high | 31.90 |
| 1y analyst estimate | 16.32 |
| Beta | 0.33 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | 2 Dec 2025 |
| Next earnings date | 26 Feb 2026 |
Downside potential
Loading...
Downside potential data
| FLRY3.SA | S&P500 | |
| Current price drop from All-time high | -52.73% | -1.08% |
| Highest price drop | -66.43% | -19.00% |
| Date of highest drop | 11 Mar 2025 | 8 Apr 2025 |
| Avg drop from high | -57.52% | -2.64% |
| Avg time to new high | - | 6 days |
| Max time to new high | 295 days | 89 days |
COMPANY DETAILS
Marketcap
8.22B
Marketcap category
Mid-cap
Description
Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and clinical research in oncology; integrated solutions, research, development of processes and services in genomics; and laboratory analysis services. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.
Employees
28000
Website
Investor relations
-
SEC filings
CEO
Country
Brazil
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Fleury SA reports an 11.5% revenue increase, driven by strategic acquisitions and robust B2C growth, despite challenges in the B2B segment.
November 8, 2025
SAO PAULO (Reuters) -Shares of Brazilian medical diagnostics company Fleury jumped on Monday after reports of a potential acquisition by hospital chain Rede D'Or, which analysts said could generate sy...
July 21, 2025
Fleury SA reports a 6.5% revenue increase and robust digital transformation, while navigating macroeconomic challenges and competitive pressures.
May 10, 2025
Fleury SA reports an 8.7% increase in quarterly revenue and successful integration with Pardini Group, despite facing operational challenges.
March 1, 2025